Biomarkers in Drug Discovery and Development: A Handbook of Practice, Application, and Strategy

-10%
Preț: 869,40 lei
966,00 lei (-10%)
Disponibilitate: la comandă
Autor: Ramin Rahbari (Editor), Jonathan Van Niewaal (Editor), Michael R. Bleavins (Editor)
ISBN: 978-1-119-18750-9
Editura: WILEY
Anul publicarii: 2020
Ediția: 2
Pagini: 608
Format: hardcover
Categoria: PHARMACOLOGY & PHARMACY
DESCRIERE
This book continues the legacy of a well-established reference within the pharmaceutical industry – providing perspective, covering recent developments in technologies that have enabled the expanded use of biomarkers, and discussing biomarker characterization and validation and applications throughout drug discovery and development.
• Explains where proper use of biomarkers can substantively impact drug development timelines and costs, enable selection of better compounds and reduce late stage attrition, and facilitate personalized medicine
• Helps readers get a better understanding of biomarkers and how to use them, for example which are accepted by regulators and which still non-validated and exploratory
• Updates developments in genomic sequencing, and application of large data sets into pre-clinical and clinical testing; and adds new material on data mining, economics, and decision making, personal genetic tools, and wearable monitoring
• Includes case studies of biomarkers that have helped and hindered decision making
• Reviews of the first edition: “If you are interested in biomarkers, and it is difficult to imagine anyone reading this who wouldn't be, then this book is for you." (ISSX) and “…provides a good introduction for those new to the area, and yet it can also serve as a detailed reference manual for those practically involved in biomarker implementation.” (ChemMedChem)
• Explains where proper use of biomarkers can substantively impact drug development timelines and costs, enable selection of better compounds and reduce late stage attrition, and facilitate personalized medicine
• Helps readers get a better understanding of biomarkers and how to use them, for example which are accepted by regulators and which still non-validated and exploratory
• Updates developments in genomic sequencing, and application of large data sets into pre-clinical and clinical testing; and adds new material on data mining, economics, and decision making, personal genetic tools, and wearable monitoring
• Includes case studies of biomarkers that have helped and hindered decision making
• Reviews of the first edition: “If you are interested in biomarkers, and it is difficult to imagine anyone reading this who wouldn't be, then this book is for you." (ISSX) and “…provides a good introduction for those new to the area, and yet it can also serve as a detailed reference manual for those practically involved in biomarker implementation.” (ChemMedChem)
Categorii de carte
-Comandă specială
-Edituri
-Promo
-Publicaţii Callisto
-Cărţi noi
-- 330,75 lei367,50 lei (-10%)
- 746,55 lei829,50 lei (-10%)
- 441,00 lei472,50 lei (-6,67%)
Promoţii
-- 15,75 lei136,50 lei (-88,46%)
- 330,75 lei367,50 lei (-10%)
- 746,55 lei829,50 lei (-10%)
REVIEW-URI